RETROSPECTIVE REVIEW OF PLAVIX RESISTANCE IN CENTRAL FLORIDA PATIENTS UNDERWENT TRANSCAROTID ARTERY REVASCULARIZATION (TCAR)

Clinical Trial Information

Trial Contact: Ngo, George M.

Trial Phone: 3218439657

IRB No: 26.091.05

Principal Investigator: El-Arousy, Hazem

Phase: N/A

Age Group: Adult

ClinicalTrials.gov ID: N/A

Objective

To describe the prevalence of documented Plavix (clopidogrel) resistance among adult patients in Central Florida who underwent Transcarotid Artery Revascularization (TCAR), using data obtained solely from existing medical records.

Share:

Related Clinical Trials

A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) versus Sunitinib in Participants with Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) after Imatinib Therapy (StrateGIST 3)
A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination with Durvalumab, Carboplatin and Etoposide Versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312)
Are Premature Infants with Bronchopulmonary Dysplasia Requiring Tracheostomy and Ventilation at Increased Risk of Atypical Craniosynostosis?
Randomized Trial Comparing Novel Fluoroscopy System with Conventional Fluoroscopy System in Fluoroscopy-Guided Endoscopic Procedures